Non-Alcoholic Steatohepatitis Supplement Market to Hit USD 1019.5 million by 2030, Research By SNS Insider

Non-Alcoholic Steatohepatitis Supplement Market Report Scope -

The SNS Insider report indicates that the Non-Alcoholic Steatohepatitis Supplement Market was valued at USD 762.4 million in 2022, and it is projected to achieve a market size of USD 1019.5 million by 2030, with a compound annual growth rate (CAGR) of 3.7% expected over the forecast period from 2023 to 2030.

Non-alcoholic steatohepatitis (NASH) is a type of a non-alcoholic fatty liver disease (NAFLD) which generally arises when the liver turns fatty. It's still not known that this disease exists, because the liver can be fat without any changes in its function. Yet, it can advance into a severe condition, which is also referred as Non-Alcoholic Steatohepatitis Supplement Market that may result in liver failure. Non-alcoholic steatohepatitis (NASH) can also be identified by the inflammation and irreversible cell death.

Get a Sample Report of Non-Alcoholic Steatohepatitis Supplement Market @ https://www.snsinsider.com/sample-request/3989

Key Players Covered in this market report are:

Nature's Bounty (Nestlé)
NOW Foods
Herbalife International of America Inc.
DANONE S.A.
ADM
Irwin Naturals
Oregon's Wild Harvest
Jarrow Formulas Inc
Gaia Herbs and Nutra-Life Australia
Intercept Pharmaceuticals Inc.
Evogen Nutrition

Market Growth Factors -

The use of certain supplements in the treatment of non-alcoholic steatohepatitis (NASH) and related metabolic disorders is being supported by a growing body of scientific research. This study has made the potential benefits of NASH supplements more widely accessible to patients and health care professionals. Clinical trials have demonstrated that Omega 3 fatty acids like those found in fish oil can help to improve liver function, reduce inflammation and enhance the lipid profile.

Segmentation Analysis -

In 2022 the segment of vitamin e and pioglitazone accounted for a 100% market share. The lack of authorised therapeutic options on the market may be a reason for the dominance of un labelled therapies. Off-label treatments like Vitamin E are the most commonly prescribed therapeutics for non-alcoholic steatohepatitis. During the forecast period, the retail and specialty pharmacy segment is expected to grow at a significant compound annual growth rate of 39.5%. Due to NASH being a chronic disease, the support for medicines is long lasting and contributes to retail pharmacies' growth. In the home care setting associated with retail pharmacies, most of the medication consumption including off label usage is expected. During the assessment period, all these factors are expected to stimulate market growth.

Non-Alcoholic Steatohepatitis Supplement Market Segmentation as Follows:

By Type
Probiotics
Pre-biotic
Synbiotics
Postbiotic

By Supplement Form
Tablet
Capsule
Powder
Others

By Nutrition
Milk thistle
Turmeric
Vitamin E
Omega-3-fatty acids

Access full Report Details @ https://www.snsinsider.com/reports/non-alcoholic-steatohepatitis-supplement-market-3989

Key Regional Development -

The largest market share of 79.63% will be held by North America from 2022 onwards. The high incidence of disease, increased healthcare costs, increasing awareness among patients and the presence of large players in this region can be explained by these factors. Moreover, the United States accounted for the highest incidence of NASH cases followed closely by Japan. Spain was the least affected among the European countries, and Germany had the highest NASH prevalence. Moreover, significant growth is expected to take place in the Asia Pacific region during this period. This is more likely due to high NASH prevalent countries such as Japan.

Key Takeaway's-

Non-Alcoholic Steatohepatitis Supplement Market Currently, pharmacological options for non-alcoholic steatohepatitis have been limited to vitamin E and the off-label use of pioglitazone, as there are no approved drugs on the market for NASH treatment. This gives rise to remunerative opportunities and fierce competition between companies for the entry into the market of first treatments. many more are currently developing novel drug therapies to target non-alcoholic steatohepatitis.

Recent Developments -

In 2023, Intercept Pharmaceuticals, Inc. announced a restructuring to improve the Company's focus on rare and critical liver disorders while dramatically reducing operating expenses, including the discontinuation of all nonalcoholic steatohepatitis (NASH)-related funding.

In 2023, Nestlé introduced Nature's Bounty in the Philippines, a line of five non-GMO (genetically modified organism) supplements with no artificial flavors, colors, or sweeteners.

In 2023, Evogen Nutrition, a pioneer in sports nutrition and supplements, introduced a new liver support supplement designed to improve liver health and performance.

Table of Content - Analysis of Key Points

1. Introduction
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession on Major Economies
5. Value Chain Analysis
6. Porter's 5 forces model
7. PEST Analysis
8. Non-Alcoholic Steatohepatitis Supplement Market Segmentation, By Type
9. Non-Alcoholic Steatohepatitis Supplement Market Segmentation, By Supplement Form
10. Non-Alcoholic Steatohepatitis Supplement Market Segmentation, By Nutrition
11. Regional Analysis
12. Company Profiles
13. Competitive Landscape
14. Conclusion

Buy this Report @ https://www.snsinsider.com/checkout/3989

Contact Us:
Akash Anand - Head of Business Development & Strategy
info@snsinsider.com
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)

About Us:
SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

This release was published on openPR.